Navigation Links
Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations
Date:1/14/2014

ssness, coughing, mucus, and other symptoms.  (For more information, visit http://www.nhlbi.nih.gov/health/health-topics/topics/copd/.)  COPD affects over 24 million people in the US and over 64 million people worldwide.  Exacerbations are an acute worsening of the disease that can lead to substantial morbidity, including lost work days, clinic or emergency room visits, and hospitalizations, and may cause death.   Understanding these events and developing new treatments to reduce their frequency, severity, and duration, are important to patients and priorities for medical research.   The EXACT was designed to advance the science through precise, standardized assessment of exacerbations to facilitate basic and applied research on exacerbations, including onset, acuity, recovery, relapse, and the effects of preventive and acute treatment.  The EXACT is being used in multiple investigations, including pharmaceutical trials and natural history studies of COPD.  

"EXACT qualification marks a major milestone in the partnership between FDA and developers of patient-focused clinical outcome assessments (COAs) targeted for clinical trial use," said Laurie Burke, former Director of CDER's Study Endpoints and Labeling Development Staff that leads the COA qualification process at FDA.  "The EXACT development process enabled FDA to pave the way for more PRO measures to be qualified for drug development.  Moreover, COPD patients in clinical trials now have a clear voice in the measurement of treatment benefit and the development of new treatments based on their symptom experience."

About Evidera
Evidera, a wholly owned subsidiary of Symphony Technology Group, provides health economics, outcomes research, market access, data analytics and epidemiology services. We partner with life sciences organization
'/>"/>

SOURCE Evidera
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
2. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
3. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
4. Misonix Announces New Distribution Agreement For Panama
5. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
6. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
7. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
8. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
9. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
10. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
11. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... May 28, 2015  Array BioPharma Inc. (NASDAQ: ... selumetinib (licensed to AstraZeneca) at the 2015 American Society ... held May 29 – June 2, 2015 in ... currently advancing in a total of 6 pivotal trials, ... NEMO (binimetinib monotherapy in NRAS mutant melanoma patients) and ...
(Date:5/28/2015)... -- Eli Lilly and Company (NYSE: LLY ) ... trial that will also be discussed in an ... Oncology (ASCO) Annual Meeting in Chicago ... superiority study of patients with locally-advanced, nonsquamous non-small ... ®  (pemetrexed for injection), in combination with cisplatin ...
(Date:5/28/2015)... , May 28, 2015  Cardinal Health today ... acquire Johnson & Johnson,s Cordis business for $1.944 billion ... after consultations with relevant works councils and trade unions. ... the United States and key non-U.S. countries ... and other customary closing conditions. Headquartered in ...
Breaking Medicine Technology:Array BioPharma Announces Clinical Data Presentations At The 2015 ASCO Annual Meeting 2Array BioPharma Announces Clinical Data Presentations At The 2015 ASCO Annual Meeting 3PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 2PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 3PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 4PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 5PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 6PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 7PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 8Cardinal Health Binding Offer To Acquire Cordis Accepted 2Cardinal Health Binding Offer To Acquire Cordis Accepted 3Cardinal Health Binding Offer To Acquire Cordis Accepted 4
... www.healthtech.net ), the Ultimate Connectivity Partner in long-term ... Quality Assurance.  In a single system, clinicians use ... to enhance quality care planning and proactive treatment.  ... Reporting for providers wanting to position successful wound ...
... Pharmaceuticals, Inc. (NASDAQ: ARNA ) announced ... Citi 2012 Global Health Care Conference on Wednesday, February 29, ... at the Waldorf=Astoria in New York City. Jack Lief, Arena,s ... corporate overview. A live audio webcast of the ...
Cached Medicine Technology:American HealthTech Announces Comprehensive Wound Management 2Arena Pharmaceuticals to Present at the Citi 2012 Global Health Care Conference 2Arena Pharmaceuticals to Present at the Citi 2012 Global Health Care Conference 3
(Date:5/28/2015)... May 28, 2015 CompanionDx ... company, announces that it will present their integrated ... testing at the annual American Society of Clinical ... sequencing evaluates the DNA in a patient’s tumor ... analyzed for key changes or somatic mutations. Pharmacogenomics ...
(Date:5/28/2015)... Beverly Hills, CA (PRWEB) May 28, 2015 ... a novel interactive keratoconus web application to ... Keratoconus has expanded in the last few years. This ... Even eye doctors are not aware of the nuances ... the Khanna Vision Institute, realized that websites can be ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Sexual ... technology that advances sexual health and wellbeing in ... University of San Francisco (USF) will be the ... sexual assault recording and reporting system. , ... transparent, and confidential reporting experience for college sexual ...
(Date:5/28/2015)... DC (PRWEB) May 28, 2015 ... designing and implementing innovative models of care for ... to support alternative reimbursements and help operationalize contracting ... Optimity also unveils a bi-weekly series of seven ... developing Outcomes Based Contracting. Optimity is a strategy, ...
(Date:5/28/2015)... May 28, 2015 Cancer survivors who ... improvements in physical activity, fitness and quality of life, ... Yale Cancer Center and Jennifer Ligibel, MD, senior physician ... Dana Farber Cancer Institute. The findings will be presented ... (ASCO) Annual Meeting in Chicago. , ...
Breaking Medicine News(10 mins):Health News:CompanionDx® Launches Integrated Genomic Solution at ASCO Meeting 2Health News:Dr.Khanna Announced the Release of an Interactive Web Application for Keratoconus Treatment 2Health News:University of San Francisco Becomes First in the Nation to Adopt College Sexual Assault Reporting System 2Health News:University of San Francisco Becomes First in the Nation to Adopt College Sexual Assault Reporting System 3Health News:Optimity Advisors Now Offers Outcomes Based Contracting Services to Support Engagement Model For New Healthcare Innovative Models of Care 2Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 2Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 3Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 4
... , , , HARRISBURG, ... individuals have received free dental care, valued at nearly $160,000, ... dental insurer United Concordia Dental. , , ... commitment to provide free preventive services to those who cannot ...
... , MIAMI, July 23 Following a ... and a leader in sports nutrition for over 40 years, continues ... weekend Twinlab,s 2009 Mobile Beach Bash ... Miami, Florida. For those eager to show-off their six-pack abs for ...
... , SUNRISE, Fla., July 23 ... delivering intelligent devices and biologics that help monitor, diagnose and ... MARVEL-1 data for presentation at the Heart Failure Society of ... , Chris O,Connor, MD, Head ...
... has shown that risky driving habits are putting young ... of their perceptions about road safety. The study surveyed ... police. Young drivers involved in the study who said ... crash. Previous research has confirmed risky, ...
... Beauty Professionals Encouraged to Share Educational Materials ... , , WASHINGTON, July 23 ... service program created to help women cope with the appearance-related changes of ... Cosmetology Association (NCA) to generate awareness and increase program participation during its ...
... , , , SAN ... OREX ) today announced that it has priced an underwritten ... a price of $7.50 per share. Net proceeds, after estimated ... $70.9 million. Orexigen has granted the underwriter a 30-day option ...
Cached Medicine News:Health News:More than 1,000 Underinsured and Uninsured Individuals Receive Free Dental Care 2Health News:Twinlab's(R) Mobile Beach Bash Heats Up After a Successful Kick-Off of the 2009 RateYourAbs.com Contest 2Health News:Bioheart Announces Acceptance of Marvel-1 Data for Presentation at the Heart Failure Society of America (HFSA) Meeting 2Health News:Bioheart Announces Acceptance of Marvel-1 Data for Presentation at the Heart Failure Society of America (HFSA) Meeting 3Health News:Risky driving puts P-platers at high danger of crash 2Health News:Look Good...Feel Better Launches Salon Awareness Campaign During National Breast Cancer Awareness Month 2Health News:Look Good...Feel Better Launches Salon Awareness Campaign During National Breast Cancer Awareness Month 3Health News:Orexigen(R) Therapeutics Prices Public Offering of Common Stock 2
1.25 mm x 2.5 mm blade. 135 degrees back scratcher. Round handle....
6 mm wide tip. Gentle tapered blade. Designated most popular model or size....
9 mm wide tip. Designated most popular model or size....
4 mm wide tip....
Medicine Products: